Back to Home
National Institute on Drug Abuse news
National Institute on Drug Abuse appears in 1 story we have published in November 2026, mostly in our Technology coverage. It is most often reported alongside University of South Florida Health.
Latest development
DEA bans SR-17018, a compound showing promise in opioid withdrawal management
The Drug Enforcement Administration (DEA) classified SR-17018, a compound studied for its potential to reduce opioid dependence without severe withdrawal symptoms, as a Schedule I substance in August 2026. The decision halts ongoing research and restricts access for individuals using it to wean off opioids.
5 November 2026
